Impact of NSAID type, initiation timing, duration and dose on clinical outcomes of immunotherapy in NSCLC: a multicenter two-cohort study.

Li Y, Jia X, Liu M, Zhu Z, Qiao H, Jiang J, Li M, Xia W, Xu L, Zhang E, Wang W, Liu J, Xu R, Qi Y, Jing G, Bai Y, Jiao M, Hu S, Liu Z, Guo H, Jiang L

Open source

DOI: 10.1136/jitc-2025-014360
Published: 2026 Apr 1
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-014360,
  title = {Impact of NSAID type, initiation timing, duration and dose on clinical outcomes of immunotherapy in NSCLC: a multicenter two-cohort study.},
  author = {Li Y and Jia X and Liu M and Zhu Z and Qiao H and Jiang J and Li M and Xia W and Xu L and Zhang E and Wang W and Liu J and Xu R and Qi Y and Jing G and Bai Y and Jiao M and Hu S and Liu Z and Guo H and Jiang L},
  year = {2026},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2025-014360},
  url = {https://doi.org/10.1136/jitc-2025-014360}
}

RIS

TY  - JOUR
TI  - Impact of NSAID type, initiation timing, duration and dose on clinical outcomes of immunotherapy in NSCLC: a multicenter two-cohort study.
AU  - Li Y
AU  - Jia X
AU  - Liu M
AU  - Zhu Z
AU  - Qiao H
AU  - Jiang J
AU  - Li M
AU  - Xia W
AU  - Xu L
AU  - Zhang E
AU  - Wang W
AU  - Liu J
AU  - Xu R
AU  - Qi Y
AU  - Jing G
AU  - Bai Y
AU  - Jiao M
AU  - Hu S
AU  - Liu Z
AU  - Guo H
AU  - Jiang L
PY  - 2026
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2025-014360
UR  - https://doi.org/10.1136/jitc-2025-014360
ER  -

APA

Y, L., X, J., M, L., Z, Z., H, Q., J, J., M, L., W, X., L, X., E, Z., W, W., J, L., R, X., Y, Q., G, J., Y, B., M, J., S, H., Z, L., H, G., & L, J. (2026). Impact of NSAID type, initiation timing, duration and dose on clinical outcomes of immunotherapy in NSCLC: a multicenter two-cohort study.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2025-014360

Source records

pubmed · retrieved 2026-09-27T09:41:26.219Z